LDLR and familial hyperaldosteronism: In fact, as these drugs work by upregulating the expression of hepatic LDLR, in HeFH statins induce the transcription of both the mutated and the wild-type allele, thus resulting in an increased expression of functional LDLR in the liver (although at a lesser extent than in non-FH individuals) and the reduction of plasma LDL-C.